Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Sonoma Pharmaceuticals, Inc. - Common Stock (NQ:SNOA)

1.250 -0.030 (-2.34%)
Delayed Quote Updated: 4:00 PM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 35,268
Open 1.310
Bid (Size) 1.250 (600)
Ask (Size) 1.280 (200)
Prev. Close 1.280
Today's Range 1.250 - 1.310
52wk Range 0.8501 - 4.600
Shares Outstanding 1,730,613
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Sonoma Pharmaceuticals Delivers 141% U.S. Revenue Growth in FY Q1, 60% Total Revenue Growth and First-Ever Positive Adjusted EBITDA
From Sonoma Pharmaceuticals, Inc.
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Receives FDA 510(k) Clearance Expanding Indications and Packaging Options for Microdacyn(R) Wound Irrigation Solution
From Sonoma Pharmaceuticals, Inc.
Via ACCESS Newswire

Performance

YTD
-65.7%
-65.7%
1 Month
-3.1%
-3.1%
3 Month
+3.3%
+3.3%
6 Month
-48.6%
-48.6%
1 Year
-67.8%
-67.8%

More News

Read More
News headline image
Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2026 Financial Results
From Sonoma Pharmaceuticals, Inc.
Via ACCESS Newswire
Unusual volume stocks are being observed in Tuesday's session. ↗
Via Chartmill
Unusual volume stocks in Monday's session ↗
Via Chartmill
News headline image
Sonoma Pharmaceuticals Announces Pricing of $4 Million Public Offering
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Announces Launch of New Dermatology Product Line under Person & Covey's Aquanil Brand for Sensitive Skin
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2026 Financial Results
Via ACCESS Newswire
News headline image
National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2026 Financial Results
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
Sonoma Pharmaceuticals and Medline Industries Launch New HOCl Wound Cleanser for U.S. Hospitals
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals Expands Market Reach with FDA Cosmetic Product Facility Registration and Microcyn-Based Cosmetic Product Listing Under MoCRA
Via ACCESS Newswire
News headline image
Sonoma Pharmaceuticals to Participate in the Lytham Partners Fall 2025 Investor Conference on September 30, 2025
Via ACCESS Newswire
News headline image
National Psoriasis Foundation Awards Seal of Recognition to Sonoma Pharmaceuticals for Reliefacyn Advanced
Via ACCESS Newswire
News headline image
5 Healthcare Stocks On Fire This Week ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Via Benzinga
News headline image
Let's take a look at the stocks that are in motion in today's session. ↗
Via Chartmill
News headline image
Which stocks are most active on Thursday? ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
Via Benzinga
News headline image
Thursday's session: top gainers and losers ↗
Via Chartmill
News headline image
There are notable gap-ups and gap-downs in today's session. ↗
Via Chartmill
News headline image
Dow Falls Over 100 Points; Deere Shares Dip After Q3 Results ↗
Via Benzinga
Topics Stocks

Frequently Asked Questions

Is Sonoma Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Sonoma Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Sonoma Pharmaceuticals, Inc. - Common Stock trade on?
Sonoma Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sonoma Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Sonoma Pharmaceuticals, Inc. - Common Stock is SNOA on the Nasdaq Stock Market
What is the current price of Sonoma Pharmaceuticals, Inc. - Common Stock?
The current price of Sonoma Pharmaceuticals, Inc. - Common Stock is 1.250
When was Sonoma Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Sonoma Pharmaceuticals, Inc. - Common Stock was at 10/01/26 04:00 PM ET
What is the market capitalization of Sonoma Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Sonoma Pharmaceuticals, Inc. - Common Stock is 2.16M
How many shares of Sonoma Pharmaceuticals, Inc. - Common Stock are outstanding?
Sonoma Pharmaceuticals, Inc. - Common Stock has 2M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS